Transcription Factor CHF1/Hey2 Regulates Specific Pathways in Serum Stimulated Primary Cardiac Myocytes: Implications

Man Yu1, Fan Xiang, Richard P Beyer

  • 1Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA.

Current Genomics
|December 2, 2010
PubMed

Insights

CHF1/Hey2 overexpression in heart cells prevents hypertrophy. This study reveals CHF1/Hey2 suppresses water transport and embryonic development pathways while promoting protein dephosphorylation and autophagy.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Gene Regulation

Background:

  • Overexpression of CHF1/Hey2 in the myocardium has been previously shown to prevent phenylephrine-induced cardiac hypertrophy.
  • Understanding the downstream transcriptional targets of CHF1/Hey2 is crucial for elucidating its role in cardiac function and disease.

Purpose of the Study:

  • To identify transcriptional pathways regulated by CHF1/Hey2 in cardiac myocytes.
  • To investigate the impact of CHF1/Hey2 overexpression on gene expression profiles in response to serum stimulation.

Main Methods:

  • Primary neonatal mouse cardiac myocytes from wild type and CHF1/Hey2 overexpressing transgenic mice were cultured.
  • Cells were treated with serum, a hypertrophic stimulus, and then subjected to microarray hybridization for transcriptional profiling.
  • Downstream target genes and biological processes were identified using single gene analysis, qRT-PCR, and Gene Set Analysis with Gene Ontology Consortium data.

Main Results:

  • CHF1/Hey2 overexpression suppressed serum-induced cardiac myocyte hypertrophy.
  • CHF1/Hey2 suppressed pathways related to water transport, adenylate cyclase activity, embryonic eye morphogenesis, gut development, and fluid transport upon serum stimulation.
  • Genes involved in protein dephosphorylation were upregulated independently of serum treatment, while genes related to transcription factor activity, nuclear export, and steroid hormone receptor signaling were overexpressed prior to serum treatment. Genes involved in autophagy, apoptosis, and mitochondrial biogenesis were overexpressed after serum treatment.

Conclusions:

  • CHF1/Hey2 plays a significant role in suppressing specific hypertrophic pathways in cardiac myocytes.
  • The findings highlight CHF1/Hey2's complex regulation of gene expression, influencing diverse biological processes including transport, development, and cellular metabolism.
  • CHF1/Hey2 targets distinct sets of genes in response to hypertrophic stimuli, suggesting a multifaceted role in maintaining cardiac homeostasis.

Related Concept Videos

Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: